Surgery – Diagnostic testing – Detecting nuclear – electromagnetic – or ultrasonic radiation
Reexamination Certificate
2006-06-13
2006-06-13
Robert, Eduardo C. (Department: 3733)
Surgery
Diagnostic testing
Detecting nuclear, electromagnetic, or ultrasonic radiation
C424S009700
Reexamination Certificate
active
07062312
ABSTRACT:
A method and combination including a visual marker for monitoring a patient to determine compliance with a medication regimen. An orally administrable medication composition is provided in combination with a visual marker. When the combination is orally ingested, the marker causes a coloration or discoloration of the oral and/or pharyngeal cavity of a subject. By visually observing the oral and/or pharyngeal cavity of the subject, one can determine whether medication has been ingested based upon the presence or absence of the coloration/discoloration.
REFERENCES:
patent: 3260646 (1966-07-01), Paulsen
patent: 3309274 (1967-03-01), Brilliant
patent: 3409721 (1968-11-01), Applezweig
patent: 3427377 (1969-02-01), Bauer et al.
patent: 3723613 (1973-03-01), Block et al.
patent: 3772200 (1973-11-01), Livesay
patent: 3852413 (1974-12-01), Cammarata
patent: 3928560 (1975-12-01), Neely et al.
patent: 4152412 (1979-05-01), Brewer
patent: 4390452 (1983-06-01), Stevens
patent: 4431628 (1984-02-01), Gaffar
patent: 4568534 (1986-02-01), Stier et al.
patent: 4752448 (1988-06-01), Wells et al.
patent: 4875858 (1989-10-01), Jefferies et al.
patent: 5039616 (1991-08-01), Copelan
patent: 5126145 (1992-06-01), Evenstad et al.
patent: 5179027 (1993-01-01), Fisher
patent: 5196435 (1993-03-01), Clemens et al.
patent: 5378634 (1995-01-01), Sigetoh et al.
patent: 5458879 (1995-10-01), Singh et al.
patent: 5547878 (1996-08-01), Kell
patent: 5652146 (1997-07-01), Kell
patent: 5776783 (1998-07-01), Kell
patent: 5882627 (1999-03-01), Pomerantz
patent: 5885677 (1999-03-01), Gosselin et al.
patent: 5908788 (1999-06-01), Kell
patent: 6068981 (2000-05-01), Rittenburg et al.
patent: 6200604 (2001-03-01), Pather et al.
patent: 6303102 (2001-10-01), Schlichte
patent: 6432715 (2002-08-01), Nelson et al.
patent: 652760 (1962-11-01), None
patent: 1250969 (1964-08-01), None
patent: 1110329 (1968-05-01), None
patent: WO 9512812 (1995-05-01), None
patent: WO 9917747 (1999-04-01), None
patent: WO 0037114 (2000-06-01), None
patent: WO 02/056919 (2002-07-01), None
Thilothammal, N. et al.,Testing Compliance of Drug Taking—A Simple Bed Side Method, Indian Pediatrics, Mar. 1995; 32(3):295-9.
Stockert, J.C. et al.,Chromatin Fluoresence After Carmine Staining, Stain Technology, vol. 65, No. 6, p. 299.
Morgan, Jane B.,Use of Non-Absorbable Markers in Studies of Human Nutrient Absorption, Human Nutrition: Applied Nutrition (1986) 40A, 399-411.
Cerrato et al.,Marking of Naltrexone and Placebo Capsules with Riboflavin as an Indicator of Compliance, Farmacia Clinica, vol. 6, No. 10, 1989, pp. 758-760.
Del Boca et al.,Assessment of Medication Compliance in Alcoholics Through UV Light Detection of a Riboflavin Tracer, Alcoholism, Clinical and Experimental Research, United States, Nov., 1996, vol. 20, No. 8, pp. 1412-1417.
International Search Report, PCT/US02/01167, May 6, 2003.
Partial European Search Report, Jul. 23, 2004.
Gonzales Gilbert R.
Griggs Roger D.
PediaMed Pharmaceuticals, Inc.
Ramana Anuadha
Robert Eduardo C.
Wood Herron & Evans L.L.P.
LandOfFree
Combination and method including a visual marker for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination and method including a visual marker for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination and method including a visual marker for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3617251